Publications by authors named "Alexandre Lopez-Gavin"

Claim this Profile
E
Epitope mapping of SARS-CoV-2 Spike protein using naturally-acquired immune responses to develop monoclonal antibodies.
Rubén López-Aladid, Leticia Bueno-Freire, Roc Farriol-Duran, Eduard Porta-Pardo, Ruth Aguilar

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Complete Approach for circRNA Therapeutics from Purification to Lyophilized Delivery Using Novel Ionizable Lipids.
Esther Broset, Ana Larraga, Verónica Lampaya, Víctor Navarro, Alexandre López-Gavín

Int J Mol Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Lung- and Spleen-Targeted mRNA Delivery with Biodegradable Ionizable Lipids in Four-Component LNPs.
Juan Heredero, Álvaro Peña, Esther Broset, Beatriz Blandín, Diego de Miguel

Pharmaceutics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Antibiotics and Potential Antibiofilm Agents against Biofilm-Producing - Complex Causing Chronic Pulmonary Infections.
Elena Portell-Buj, Cecibel González-Criollo, Alexandre López-Gavín, Mariana Fernández-Pittol, Maria Antònia Busquets

Antibiotics (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study.
Anna Motos, Alexandre López-Gavín, Jordi Riera, Adrián Ceccato, Laia Fernández-Barat

Eur Respir J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Elena Portell-Buj, Queralt Bonet-Rossinyol, Alexandre López-Gavín, Angely Roman, Mariana Fernández-Pittol

J Antibiot (Tokyo)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Biofilm Formation in Mycobacterium avium-intracellulare Complex.
Elena Portell-Buj, Alexandre López-Gavín, Julian González-Martín, Griselda Tudó

Arch Bronconeumol (Engl Ed)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of a Novel Quinolone, UB-8902, Against Ofloxacin-Resistant Isolates.
Griselda Tudó, Alexandre Lopez-Gavin, Elena Portell-Buj, Joan Freixes, Jordi Vila

Microb Drug Resist· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
Elena Portell-Buj, Andrea Vergara, Izaskun Alejo, Alexandre López-Gavín, Maria Rosa Monté

J Med Microbiol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing.
Fernanda Teixeira Subtil, Anne Drumond Villela, Bruno Lopes Abbadi, Valnês S Rodrigues-Junior, Cristiano Valim Bizarro

Int J Antimicrob Agents· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection.
Valnês S Rodrigues-Junior, Anne D Villela, Raoni S B Gonçalves, Bruno Lopes Abbadi, Rogério Valim Trindade

Int J Antimicrob Agents· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro time-kill curves study of three antituberculous combinations against Mycobacterium tuberculosis clinical isolates.
Alexandre López-Gavín, Griselda Tudó, Emma Rey-Jurado, Andrea Vergara, Juan Carlos Hurtado

Int J Antimicrob Agents· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
Alexandre López-Gavín, Griselda Tudó, Andrea Vergara, Juan Carlos Hurtado, Julian Gonzalez-Martín

Int J Antimicrob Agents· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis